Company / Operating Cash Flow per Share
Adaptive Biotechnologies Corp Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.31
FY2025
5-year range
-$1.40 / -$0.31
FY2021-FY2025
Trend
+52.6%
vs FY2024
Sector context
#87 of 212
Health Care
What the data says
At $-0.31, Adaptive Biotechnologies Corp's operating cash flow per share ranks #87 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 4 consecutive years, from $-1.40 in FY2021 to $-0.31 in FY2025.
Based on SEC 10-K filings.
-0.31 in FY2025.
Improved from $-1.09 to $-0.31 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#87 of 212 in Health CareTop 41% of 212This company -$0.31 Sector average $5.28
▼
-105.9% below sector average
Key checks
Key Insights
- Adaptive Biotechnologies Corp's operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 52.6% year-over-year.
- Ranks #87 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.31 | +52.6% |
| FY2024 | -$0.66 | +39.9% |
| FY2023 | -$1.09 | +16.0% |
| FY2022 | -$1.30 | +7.1% |
| FY2021 | -$1.40 | -17.1% |
| FY2020 | -$1.20 | -107.5% |
| FY2019 | $16.00 | +726.2% |
| FY2018 | -$2.55 | +10.6% |
| FY2017 | -$2.86 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026